Gesynta Pharma raises 26.5 MEUR

(Stockholm, is developing a drug candidate for the treatment of endometriosis): Has raised 26.5 MEUR in a funding round led by Innovestor Life Science, with participation from Hadean VenturesLincForeground CapitalCatalyze CapitalStephen IndustriesAmboy Street Ventures, and Industrifonden with member Peter Wolpert. The funding will support a Phase II clinical trial in Europe.


Posted

in

by

Tags: